Neuraxis, INC SEC filings NRXS
Neuraxis, INC has 193 filings in SEC EDGAR's recent list, going back to Sep 27, 2022. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 19, 2026 | Jul 24, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | Aug 6, 2026 | — |
| EFFECT | Filing | Aug 3, 2026 | — |
| S-3/A | Filing | Jul 30, 2026 | — |
| S-3 | Shelf registration | Jul 23, 2026 | — |
| S-8 | Employee stock plan registration | Jul 10, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 10, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 22, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 21, 2026 | Apr 21, 2026 |
| 424B5 | Prospectus supplement | Apr 21, 2026 | — |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 23, 2025 | Oct 23, 2025 |
| 424B5 | Prospectus supplement | Oct 23, 2025 | — |
| S-8 | Employee stock plan registration | Oct 8, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 2, 2025 | Aug 29, 2025 |
| 424B5 | Prospectus supplement | Aug 29, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change
|
Jul 3, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | May 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2025 | May 23, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
May 22, 2025 | May 20, 2025 |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 21, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | Apr 14, 2025 | — |
| DEF 14A | Proxy statement | Apr 14, 2025 | May 29, 2025 |
| ARS | Annual report to shareholders | Apr 4, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 29, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| EFFECT | Filing | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| S-3/A | Filing | Feb 5, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jan 8, 2025 | Jan 8, 2025 |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| S-3 | Shelf registration | Dec 13, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2024 | Nov 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 21, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 15, 2024 | Nov 9, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 18, 2024 | Oct 12, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Sep 13, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 21, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 5, 2024 | Jun 28, 2024 |
| ARS | Annual report to shareholders | Jul 1, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jul 1, 2024 | — |
| DEF 14A | Proxy statement | Jul 1, 2024 | Aug 15, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 21, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2024 | May 21, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Results of operations, Restatement
|
Apr 9, 2024 | Apr 4, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2024 | Mar 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 11, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 15, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 31, 2024 | Jan 25, 2024 |
| 424B3 | Prospectus | Dec 19, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 19, 2023 | Dec 19, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 14, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Sep 22, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 21, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2023 | Aug 17, 2023 |
| 424B4 | Prospectus | Aug 11, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| EFFECT | Filing | Aug 8, 2023 | — |
| CERT | Nyse american certification | Aug 8, 2023 | — |
| 8-A12B | Filing | Aug 8, 2023 | — |
| CORRESP | Letter to the SEC | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Jul 28, 2023 | — |
| S-1/A | Amended registration statement | Jul 28, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2023 | — |
| FWP | Free writing prospectus | Jul 26, 2023 | — |
| S-1/A | Amended registration statement | Jul 21, 2023 | — |
| S-1/A | Amended registration statement | Jun 29, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 15, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| S-1/A | Amended registration statement | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2023 | — |
| FWP | Free writing prospectus | Feb 13, 2023 | — |
| S-1/A | Amended registration statement | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| S-1/A | Amended registration statement | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Jan 26, 2023 | — |
| S-1/A | Amended registration statement | Jan 26, 2023 | — |
| FWP | Free writing prospectus | Jan 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2023 | — |
| FWP | Free writing prospectus | Jan 20, 2023 | — |
| S-1 | Registration statement | Jan 10, 2023 | — |
| CORRESP | Letter to the SEC | Jan 10, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| DRS/A | Filing | Dec 12, 2022 | — |
| DRSLTR | Filing | Dec 9, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2022 | — |
| DRSLTR | Filing | Nov 9, 2022 | — |
| DRS/A | Filing | Nov 9, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2022 | — |
| DRS | Filing | Sep 27, 2022 | — |
Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NRXS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carmel, IN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1933567
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.